Afya
AFYA

$16.15

4.38%

Market Cap: $1.46B

About: Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

Employees: 10,181

0

Funds holding %

of 6,686 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

700% more call options, than puts

Call options by funds: $16K | Put options by funds: $2K

0.95% more ownership

Funds ownership: 26.59% [Q1] → 27.54% (+0.95%) [Q2]

0% more funds holding

Funds holding: 62 [Q1] → 62 (+0) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

9% less capital invested

Capital invested by funds: $237M [Q1] → $215M (-$21.6M) [Q2]

28% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 25

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$19

18%

upside

Avg. target

$19.25

19%

upside

High target

$19.50

21%

upside

2 analyst ratings

0 positive

0%

2 neutral

100%

0 negative

0%

UBS Andre Salles 0 / 0 met price target	21%upside $19.50	Neutral Initiated	30 Aug 2024
Morgan Stanley Mauricio Cepeda 50% 1-year accuracy 1 / 2 met price target	18%upside $19	Equal-Weight Maintained	21 Jun 2024

See Analyst Rankings

Financial journalist opinion

Based on 6 articles about AFYA published over the past 30 days

Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that following the conclusion of an administrative procedure, the Ministry of Education (“MEC”), has granted the request for reconsideration submitted by Universidade do Grande Rio Professor José de Souza Herdy (“Unigranrio”). Per the e-MEC portal, Unigranrio reestablished 10 medical seats in.

Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio

Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., has received the total disbursement of BRL500.0 million under the loan agreement with International Finance Corporation ("IFC") to support the Company's expansion program. The financing is IFC's first sustainability-linked loan based o.

Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Afya's Q2 2024 results showed stable operations with 14% revenue growth, driven by increased enrollment and tuition, and improved operating margins. A favorable Supreme Court ruling on medical seat openings and new financing from the IFC are positive developments for Afya. Despite short-term stability, long-term concerns arise due to potential oversupply in Brazil's medical education and profession markets.

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Zacks Investment Research

Afya (AFYA) Surpasses Q2 Earnings and Revenue Estimates

Afya (AFYA) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.29 per share a year ago.

Afya (AFYA) Surpasses Q2 Earnings and Revenue Estimates

Afya Limited Announces Second-Quarter and First-Half 2024 Financial Results

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and six-month period, which ended on June 30, 2024 (second quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2024 Highlights 2Q2.

Afya Limited Announces Second-Quarter and First-Half 2024 Financial Results

Afya Limited (AFYA) Q2 2024 Earnings Call Transcript

Afya Limited (NASDAQ:AFYA ) Q2 2024 Earnings Conference Call August 14, 2024 5:00 PM ET Corporate Participants Renata Couto - Investor Relations Virgilio Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Mirela Oliveira – Bank of America Lucca Marquezini - Itau Leandro Bastos - Citi Marcelo Santos - JPMorgan Mauricio Cepeda - Morgan Stanley Renata Couto Thank you for joining us for Afya's Conference Call. I'm here today with Afya's CEO, Virgilio Gibbon, and our CFO, Luis Andre Blanco.

Afya Limited (AFYA) Q2 2024 Earnings Call Transcript

Afya Secures Loan of up to R$500 Million From IFC to Support the Company's Expansion

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., entered into a loan agreement with International Finance Corporation ("IFC") to finance its expansion program, through acquisitions. The financing is IFC's first sustainability-linked loan based on social targets in the education secto.

Afya Secures Loan of up to R$500 Million From IFC to Support the Company's Expansion

Zacks Investment Research

Best Growth Stocks to Buy for August 6th

PPC, AFYA and PDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 6, 2024.

Best Growth Stocks to Buy for August 6th

Zacks Investment Research

New Strong Buy Stocks for August 6th

EVER, PPC, SFM, KBH and AFYA have been added to the Zacks Rank #1 (Strong Buy) List on August 6, 2024.

New Strong Buy Stocks for August 6th

Afya Limited Releases 2023 Sustainability Report

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34), the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2023 Sustainability Report. The document, which presents Afya's trajectory throughout 2023, follows the Global Reporting Initiative (GRI) standards and is aligned with the Sustainable Development Goals (SDGs). It also reports specific indicators from the Sustainability Accounting Standards Board (SASB) an.

Afya Limited Releases 2023 Sustainability Report

See News Rankings